PR Newswire
31 Aug 2023, 12:09 GMT+10
DUBAI, UAE, Aug. 31, 2023 /PRNewswire/ -- Dalma Capital, a global alternative investment management platform and advisor, announced today it advised Philippine fintech startup Salmon on a US$20 million debt financing deal, the largest such financing for a Series A company from the Philippines.
The debt transaction, backed by emerging-markets specialist investment firm Argentem Creek Partners, is also the largest of its kind in Southeast Asia in a year. The financing will allow the credit-led fintech firm to further scale its lending operations across the Philippines.
The transaction was completed despite volatility in the credit markets.
"Credit market volatility and the demise of certain traditional lenders to growth stage tech companies has created a vacuum in the marketplace, which alternative credit funds appear selectively prepared to fill," said Mr. John Porter, Managing Director at Dalma Capital, who led the team that advised on the transaction.
"In addition, while in the past many Southeast Asian deals were being funded from Singapore and Hong Kong, we are seeing a lot more interest from investors in the Middle East and the West, which is a break with precedent," Mr. Porter added.
Separately, Salmon has also secured financial backing from other influential investors. Notably, DisruptAD (Abu Dhabi sovereign wealth fund ADQ's venture platform) is among the firm's key supporters.
About Dalma Capital:
Dalma Capital Management Limited is a global alternative investment management platform and advisor with strong capabilities in investment banking advisory and fund management services. Dalma Capital has established itself as a leading 'bulge boutique' investment banking advisory business in the Middle East, while operating an award-winning fund platform that offers portfolio managers access to top-tier operational, regulatory, legal, and technological infrastructure. It has also recently expanded into the outsourced chief investment officer space with the addition of The Global CIO Office to the group. Principally established in the Dubai International Financial Centre in 2013 by Mr. Zachary Cefaratti, Dalma Capital is authorized and supervised by the Dubai Financial Services Authority under a prudential category 3c license.
Get a daily dose of Singapore Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Singapore Star.
More InformationTORONTO, Canada - Tens of thousands of people from across Canada have marched in support of Israel in a massive turnout in Toronto....
BOSTON, Massachusetts: U.S. President Donald Trump's administration has taken away Harvard University's right to enroll international...
WASHINGTON, DC - U.S. President Donald Trump on Monday said he believed God was behind his election loss in 2020, even though he has...
NEW YORK CITY, New York: Passenger numbers at Newark Liberty International Airport in New Jersey have dropped sharply, according to...
BRUSSELS, Belgium: European Union antitrust regulators are examining fees imposed by payment giants Visa and Mastercard, Bloomberg...
WASHINGTON, D.C.: The U.S. Army plans to change the records of transgender soldiers to list only their sex at birth, according to a...
NEW YORK, New York - Strong economic data jump-started U.S. stocks and the dollar Tuesday, a welcome reprieve after weeks of pressure...
NEW YORK CITY, New York: This week, the U.S. Federal Trade Commission (FTC) dropped its lawsuit against PepsiCo, which had accused...
WASHINGTON, D.C.: New single-family home sales in the U.S. rose sharply in April to their highest level in over three years as builders...
VEVEY, Switzerland: Nestle is realigning its focus on its core food and beverage operations after expanding into areas like health...
DEARBORN, Michigan: Ford Motor Company has filed a lawsuit against several California lawyers and law firms, accusing them of cheating...
BRUSSELS, Belgium: U.S. drugmakers are charging significantly more for new treatments, particularly those targeting rare diseases,...